Menu
University research directory
Research labs at
University of Nebraska Medical Center.
Compare 5 listed faculty-led profiles, explore their research interests, and follow the evidence in their selected work. These listings are a starting point for discovery and do not establish recruiting availability.
Explore the research before reaching out
Review each lab’s official website and recent publications. Compare the methods used, the questions being asked, and the practical requirements of any published opening. Unclaimed profiles are independently curated; the university has not approved or endorsed them.
How to compare research labs ↗Official university website ↗5 research-led lab profiles
Browse labs by their listed college affiliationHoward E. Gendelman Research Group
University of Nebraska Medical Center
Howard E. Gendelman · Professor
Gendelman connects immune biology with new approaches to infectious and neurodegenerative disease. His laboratory investigates long-acting antiretroviral delivery, gene editing, and immune-directed strategies for protecting the brain. Research combines brain and immune-cell cultures, animal models, microscopy, proteomics, and measurements of drug delivery through immune cells. Other projects explore protective T-cell responses and delivery approaches relevant to Parkinson’s disease. The group offers an interdisciplinary research direction where pharmacology, nanomedicine, and neuroimmunology meet; experimental disease-model results are presented as research rather than evidence of a broadly available cure.
Michael A. Hollingsworth Research Group
University of Nebraska Medical CenterMichael A. Hollingsworth · Professor
Hollingsworth investigates pancreatic disease through the biology of epithelial cells and mucin-associated molecules. His laboratory studies MUC1, including its expression and processing in normal cells compared with pancreatic cancer and other disease conditions. Research combines molecular biology, biochemistry, cell biology, and immunology, while developing antibodies and tumor-vaccine reagents that target tumor-associated mucin antigens. Other work supports discovery and validation of biomarkers for early pancreatic disease. The group connects detailed molecular mechanisms with diagnostic and immunotherapy research, making the transition from normal tissue biology to tumor behavior a central question.
Nanomedicines and Translational Research Laboratory
University of Nebraska Medical CenterRam I. Mahato · Professor
Mahato investigates how a therapy reaches the tissue where it is needed. His Nanomedicines and Translational Research Laboratory develops micelles, nanoparticles, polymers, and lipid-based systems for delivering drugs and nucleic acids, including siRNA and miRNA. Projects examine cancer, liver disease, and type 1 diabetes, alongside approaches to drug resistance and disease-related signaling. The group studies how delivery-system components affect drug deposition, tumor vessels, and surrounding tissue. This connects chemistry and formulation design with biological evaluation, aiming to improve targeted delivery and reduce unwanted effects on healthy tissue.
Shilpa Buch Research Group
University of Nebraska Medical CenterShilpa Buch · Professor
Buch investigates how HIV, inflammatory signaling, and substance exposure affect the nervous system. Her laboratory studies the interactions between viral proteins and resident brain cells, including pathways that produce neuronal injury or support neuronal survival. Work connects cell culture with animal models and human tissue, and includes chemokines, oxidative stress, and the effects of opioids or cocaine on HIV-related pathology. The group also studies aging in NeuroAIDS. For prospective researchers, the central opportunity is tracing how infection and immune activation alter brain function and identifying mechanisms that could support protective therapeutic strategies.
Surinder K. Batra Research Group
University of Nebraska Medical CenterSurinder K. Batra · Professor
Batra studies the molecular changes that drive pancreatic, ovarian, and prostate tumors. His laboratory investigates mucins and tumor-associated genes, linking altered growth and differentiation with potential diagnostic and therapeutic targets. Research interests include cancer diagnostics, vaccine approaches, monoclonal antibodies, and antibody engineering. UNMC describes a broader aim of understanding the mechanisms behind transformation and progression rather than studying a tumor as a single static state. The group offers prospective researchers a connection between cancer biochemistry and translational tools, where molecular characteristics can help frame strategies for detection and intervention.
Showing 1–5 of 5 labs